Physician's Weekly
JUNE 21, 2025
Artificial intelligence promises to transform primary care, guided by strong leadership, data security, and collaboration. Researchers conducted a retrospective study published in June 2025 in the issue of BMC Primary Care to synthesize evidence on the opportunities, challenges, and requirements of implementing artificial intelligence (AI) which (..)
Physician's Weekly
JUNE 18, 2025
WEDNESDAY, June 18, 2025 (HealthDay News) — The Dietary Approaches to Stop Hypertension for Diabetes (DASH4D) diet with lower sodium is tied to clinically meaningful blood pressure reduction in people with diabetes, according to a study published online June 9 in JAMA Internal Medicine. Pilla, M.D., Pilla, M.D.,
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Physician's Weekly
JUNE 17, 2025
The PATHWEIGH trial aims to embed structured obesity care into primary care, addressing barriers and boosting clinician confidence and patient outcomes. Barriers include time constraints, lack of training in obesity treatment, limited reimbursement, and the absence of structured care pathways.
Physician's Weekly
JUNE 22, 2025
They enrolled Colorado primary care practices interested in CGM and allowed them to either adopt the American Academy of Family Physicians (AAFP) Transformation in Practice Series (TIPS): CGM implementation modules or refer individuals to a virtual CGM initiation and education service led by a primary care multidisciplinary team.
Physician's Weekly
JUNE 25, 2025
WEDNESDAY, June 25, 2025 (HealthDay News) — For adult women with overweight or obesity and type 2 diabetes (T2D), replacing diet beverages (DBs) with water is associated with greater weight loss and T2D remission, according to a study presented at the annual meeting of the American Diabetes Association, held from June 20 to 23 in Chicago.
Physician's Weekly
JUNE 25, 2025
from the Velocity Clinical Research Center at Medical City Dallas, and colleagues conducted a phase 3 trial involving participants with type 2 diabetes treated only with diet and exercise, an HbA1c level of ≥7.0 Abstract/Full Text (subscription or payment may be required) More Information Copyright © 2025 HealthDay.
Physician's Weekly
JUNE 11, 2025
WEDNESDAY, June 11, 2025 (HealthDay News) — The U.S. Widaplik is not to be coadministered with aliskiren in patients with diabetes, and a boxed warning indicates discontinuation of Widaplik during pregnancy. More Information Copyright © 2025 HealthDay. ” The approval of Widaplik was granted to George Medicines.
Expert insights. Personalized for you.
97 
Let's personalize your content